169 related articles for article (PubMed ID: 36587394)
21. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Cheng L; Ren P; Shi J; Dai L; Wang P; Zhang J
Oncoimmunology; 2020 Sep; 9(1):1814515. PubMed ID: 33457096
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma.
Zhuang L; Huang C; Ning Z; Yang L; Zou W; Wang P; Cheng CS; Meng Z
Int J Cancer; 2023 Mar; 152(5):1013-1024. PubMed ID: 36274627
[TBL] [Abstract][Full Text] [Related]
23. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
24. Integration of IgG and IgA autoantibodies for early diagnosis of hepatocellular carcinoma.
Yang T; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Qiu F; Huang Y
Clin Chim Acta; 2021 Dec; 523():423-429. PubMed ID: 34728178
[TBL] [Abstract][Full Text] [Related]
25. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma.
Yau WY; Shih HC; Tsai MH; Sheu JC; Chen CH; Chow LP
J Proteomics; 2013 Dec; 94():346-58. PubMed ID: 24125732
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
27. Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.
Liu T; Liu D; Liu R; Jiang H; Yan G; Li W; Sun L; Zhang S; Liu Y; Guo K
Sci Rep; 2017 Jan; 7():38918. PubMed ID: 28079114
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract][Full Text] [Related]
29. Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes.
Wang K; Li M; Qin J; Sun G; Dai L; Wang P; Ye H; Shi J; Cheng L; Yang Q; Qiu C; Jiang D; Wang X; Zhang J
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32443439
[TBL] [Abstract][Full Text] [Related]
30. Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer.
Wang Y; Li J; Zhang X; Liu M; Ji L; Yang T; Wang K; Song C; Wang P; Ye H; Shi J; Dai L
Clin Immunol; 2023 Jan; 246():109206. PubMed ID: 36528251
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.
Zhang JY; Tan EM
Expert Rev Mol Diagn; 2010 Apr; 10(3):321-8. PubMed ID: 20370589
[TBL] [Abstract][Full Text] [Related]
32. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
[TBL] [Abstract][Full Text] [Related]
33. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
34. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
[TBL] [Abstract][Full Text] [Related]
35. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
[TBL] [Abstract][Full Text] [Related]
37. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
38. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
39. Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.
Heo CK; Hwang HM; Lee HJ; Kwak SS; Yoo JS; Yu DY; Lim KJ; Lee S; Cho EW
Sci Rep; 2019 Jul; 9(1):11059. PubMed ID: 31363116
[TBL] [Abstract][Full Text] [Related]
40. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
